Home › Kanser sa Pantog › Texas › Austin
Pag-aaral pangklinika para sa Kanser sa Pantog sa Austin, TX
Isang pag-aaral para sa Kanser sa Pantog ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Austin. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Nagre-recruitPhase 3
- Texas Oncology, Austin
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)
Nagre-recruitPhase 2
- Texas Oncology-Austin Central ( Site 0107), Austin
- Urology Austin, PLLC ( Site 0109), Austin
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Nagre-recruitPhase 1/2
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
- Texas Oncology - Central/South Texas, Austin
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Nagre-recruitPhase 3
- USO-Texas Oncology-Central/South Texas, Austin
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
- Texas Oncology (Balcones) - SCRI, Austin
A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)
Nagre-recruitPhase 1/2
- Urology Austin, PLLC ( Site 0008), Austin
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
Nagre-recruitPhase 2
- Urology Austin, PLLC (Urology America), Austin
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Nagre-recruitPhase 2
- Urology Austin, LLC, Austin
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
Nagre-recruitPhase 1/2
- Urology Austin, Austin
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Nagre-recruitPhase 2/3
- Local Institution - 0187, Austin
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Nagre-recruit
- Austin Urology Institute, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Elligo Health Research, Inc., Austin
Pag-aaral para sa Kanser sa Pantog sa ibang lungsod
- New York City, NY34 pag-aaral
- Nashville, TN31 pag-aaral
- Houston, TX31 pag-aaral
- Dallas, TX27 pag-aaral
- Washington, DC26 pag-aaral
- Boston, MA26 pag-aaral
- Los Angeles, CA24 pag-aaral
- Baltimore, MD24 pag-aaral
- St. Louis, MO22 pag-aaral
- Edison, NJ22 pag-aaral
- Philadelphia, PA21 pag-aaral
- Chicago, IL21 pag-aaral
Iba pang pag-aaral sa Austin
- Non-Small Cell Lung Cancer30 pag-aaral
- Kanser (lahat ng uri)21 pag-aaral
- Obesity20 pag-aaral
- Colorectal Cancer19 pag-aaral
- Metastatic Cancer19 pag-aaral
- Pagkabigo ng Puso18 pag-aaral
- Overweight18 pag-aaral
- Kanser sa Suso18 pag-aaral
- Kanser sa Ovary17 pag-aaral
- Kanser ng Endometrium16 pag-aaral
- Kanser sa Prostate15 pag-aaral
- Depression14 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.